Complement Inhibitors in Clinical Trials for Glomerular Diseases

被引:94
作者
Zipfel, Peter F. [1 ,2 ]
Wiech, Thorsten [3 ]
Rudnick, Ramona [1 ]
Afonso, Sara [1 ]
Person, Fermin [3 ]
Skerka, Christine [1 ]
机构
[1] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany
[2] Friedrich Schiller Univ, Jena, Germany
[3] Univ Hosp Hamburg Eppendorf, Inst Pathol, Hamburg, Germany
关键词
inhibitors; clinical trials; glomerular disease; C3; glomerulopathy; complement; ANCA; aHUS; DOMAIN-CONTAINING; 7A; H-RELATED PROTEINS; IGA NEPHROPATHY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; GENETIC-VARIANTS; C-TERMINUS; ECULIZUMAB; AUTOANTIBODIES; INSIGHTS; CFHR1;
D O I
10.3389/fimmu.2019.02166
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Defective complement action is a cause of several human glomerular diseases including atypical hemolytic uremic syndrome (aHUS), anti-neutrophil cytoplasmic antibody mediated vasculitis (ANCA), C3 glomerulopathy, IgA nephropathy, immune complex membranoproliferative glomerulonephritis, ischemic reperfusion injury, lupus nephritis, membranous nephropathy, and chronic transplant mediated glomerulopathy. Here we summarize ongoing clinical trials of complement inhibitors in nine glomerular diseases and show which inhibitors are used in trials for these renal disorders (http://clinicaltrials.gov).
引用
收藏
页数:13
相关论文
共 69 条
[1]   Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) [J].
Abrera-Abeleda, M. A. ;
Nishimura, C. ;
Smith, J. L. H. ;
Sethi, S. ;
McRae, J. L. ;
Murphy, B. F. ;
Silvestri, G. ;
Skerka, C. ;
Jozsi, M. ;
Zipfel, P. F. ;
Hageman, G. S. ;
Smith, R. J. H. .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (07) :582-589
[2]   Complement-Mediated Glomerular Diseases: A Tale of 3 Pathways [J].
Bomback, Andrew S. ;
Markowitz, Glen S. ;
Appel, Gerald B. .
KIDNEY INTERNATIONAL REPORTS, 2016, 1 (03) :148-155
[3]   Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis [J].
Bomback, Andrew S. ;
Smith, Richard J. ;
Barile, Gaetano R. ;
Zhang, Yuzhou ;
Heher, Eliot C. ;
Herlitz, Leal ;
Stokes, M. Barry ;
Markowitz, Glen S. ;
D'Agati, Vivette D. ;
Canetta, Pietro A. ;
Radhakrishnan, Jai ;
Appel, Gerald B. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (05) :748-756
[4]   Vasculitis update: pathogenesis and biomarkers [J].
Brogan, Paul ;
Eleftheriou, Despina .
PEDIATRIC NEPHROLOGY, 2018, 33 (02) :187-198
[5]   Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth [J].
Coulthard, Liam G. ;
Woodruff, Trent M. .
JOURNAL OF IMMUNOLOGY, 2015, 194 (08) :3542-3548
[6]   Primary Membranous Nephropathy [J].
Couser, William G. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (06) :983-997
[7]   Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice [J].
Danobeitia, Juan S. ;
Ziemelis, Martynas ;
Ma, Xiaobo ;
Zitur, Laura J. ;
Zens, Tiffany ;
Chlebeck, Peter J. ;
Van Amersfoort, Edwin S. ;
Fernandez, Luis A. .
PLOS ONE, 2017, 12 (08)
[8]   Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN [J].
Donadelli, Roberta ;
Pulieri, Patrizia ;
Piras, Rossella ;
Iatropoulos, Paraskevas ;
Valoti, Elisabetta ;
Benigni, Ariela ;
Remuzzi, Giuseppe ;
Noris, Marina .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[9]   Anti-complement-factor H-associated glomerulopathies [J].
Dragon Durey, Marie-Agnes ;
Sinha, Aditi ;
Togarsimalemath, Shambhuprasad Kotresh ;
Bagga, Arvind .
NATURE REVIEWS NEPHROLOGY, 2016, 12 (09) :563-578
[10]   10 most important contemporary challenges in the management of SLE [J].
Felten, Renaud ;
Sagez, Flora ;
Gavand, Pierre-Edouard ;
Martin, Thierry ;
Korganow, Anne-Sophie ;
Sordet, Christelle ;
Javier, Rose-Marie ;
Soulas-Sprauel, Pauline ;
Riviere, Marianne ;
Scher, Florence ;
Poindron, Vincent ;
Guffroy, Aurelien ;
Arnaud, Laurent .
LUPUS SCIENCE & MEDICINE, 2019, 6 (01)